Related Experiment Video
Updated: May 16, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Drug interaction between tacrolimus and ertapenem in renal transplantation recipients
F Bora1, I Aliosmanoglu, H Kocak
1Department of General Surgery, Dicle University Medical Facility, Diyarbakir, Turkey.
Abstract:
To show drug interactions between tacrolimus and ertapenem, we retrospectively evaluated 13 renal transplant recipients who had been treated with ertapenem for urinary tract infections during prescription of a constant dose. The mean dose of tacrolimus to achieve desired therapeutic concentrations decreased significantly after beginning ertapenem. The decrease from 0.079 mg/kg to 0.043 mg/kg occurred 2 days after initiation of ertapenem (P < .005). These results suggest that ertapenem, which is not metabolized through the cytochrome (CYP) P450 3A metabolic pathway, interacts with tacrolimus by an unknown mechanism. This report recommends tacrolimus concentration monitoring and dose reductions when the two drugs are administered in combination.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Drug Elimination by Renal Route: Tubular Secretion
Kidney Transplant I: Introduction
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
